Please use this identifier to cite or link to this item:
http://20.193.157.4:9595/xmlui/handle/123456789/1881Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Palit A. | - |
| dc.date.accessioned | 2020-01-31T05:41:46Z | - |
| dc.date.available | 2020-01-31T05:41:46Z | - |
| dc.date.issued | 2009 | - |
| dc.identifier.uri | http://hdl.handle.net/123456789/1881 | - |
| dc.description.abstract | antly to the disease morbidity and occasional mortality. Continuing episodes of reactions even after ‘release from treatment’ and nerve impairment related deformities are challenges in management of these patients. Recurrent leprosy reactions necessitate longterm treatment, often for indefinite period | en_US |
| dc.language.iso | en | en_US |
| dc.publisher | BLDE(Deemed to be University) | en_US |
| dc.subject | The clinical course of leprosy is altered by episodes of type 1 and type 2 reactions. This adds | en_US |
| dc.title | Management of leprosy reactions: Facing the realities. | en_US |
| dc.type | Article | en_US |
| Appears in Collections: | Faculty of Dermatology | |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.